The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus. The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").
The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus. This virus has been named “SARS-Cov-2” and the disease it causes has been named “coronavirus disease 2019” (abbreviated “COVID-19”).
The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus. The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").
The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus. The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").
During this event, MHD is adding two additional albuterol inhalers as preferred products. The list of preferred beta adrenergic short acting inhalers is:
The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus. The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").
For Pharmacy claims, MO HealthNet requires documentation of “offer to counsel” and also requires maintenance of a signature log to prove the prescription was delivered and received. This requirement is in section 13.11.B of the MO HealthNet Pharmacy Provider Manual.
The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus. The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").
The MHD recognizes that testing centers that administer the test required for the Registered Behavior Technician® credential are closed as of March 16, 2020 due to COVID-19.
MO HealthNet has received several questions regarding telephoning a prescription for controlled substances due to the COVID19 Pandemic.
E-Prescribing is allowed for all schedules if in compliance with BNDD/DEA requirements.
The requirements of a telephoned controlled substance prescription are BNDD/DEA requirements and are not under the authority of MO HealthNet. For your reference, the requirements are below for a CII prescription to be called in to a pharmacy:
§1306.11 Requirement of prescription.
The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus. The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").
An email address has been set up for provider questions related to billing for COVID-19 testing, treatment, services provided via telehealth, etc.
MO HealthNet will respond to these questions and track the inquiries to compile FAQ’s that will be posted on the Education/Training webpage.
To expedite provider enrollment into the MO HealthNet program (Missouri's Medicaid program), Missouri Medicaid Audit & Compliance (MMAC) is providing same day or overnight approvals of most new provider enrollment applications for physicians, advanced practice nurses, and other licensed practitioners. Visit https://mmac.mo.gov/providers/ for more information.
The MO HealthNet Division (MHD) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus. The virus has been named "SARS-CoV-2" and the disease it causes has been named "coronavirus disease 2019" (abbreviated "COVID-19").
The MHD’s Radiology Benefit Manager is currently auto approving Chest CT Scan HCPCS codes 71250, 71260, and 71270 when the following COVID-19 related diagnosis codes are present: B34.2, B97.29, J20.8, J22, J40, J80, J98.8, Z03.818, and Z20.828. The prior authorizations for these tests will be approved for 90 days.
